These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 14611670

  • 1. Enhancement of urinary bladder carcinogenesis by combined treatment with benzyl isothiocyanate and N-butyl-N-(4-hydroxybutyl)nitrosamine in rats after initiation.
    Okazaki K, Umemura T, Imazawa T, Nishikawa A, Masegi T, Hirose M.
    Cancer Sci; 2003 Nov; 94(11):948-52. PubMed ID: 14611670
    [Abstract] [Full Text] [Related]

  • 2. Simultaneous treatment with benzyl isothiocyanate, a strong bladder promoter, inhibits rat urinary bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Okazaki K, Yamagishi M, Son HY, Imazawa T, Furukawa F, Nakamura H, Nishikawa A, Masegi T, Hirose M.
    Nutr Cancer; 2002 Nov; 42(2):211-6. PubMed ID: 12416262
    [Abstract] [Full Text] [Related]

  • 3. Strong promoting activity of phenylethyl isothiocyanate and benzyl isothiocyanate on urinary bladder carcinogenesis in F344 male rats.
    Hirose M, Yamaguchi T, Kimoto N, Ogawa K, Futakuchi M, Sano M, Shirai T.
    Int J Cancer; 1998 Aug 31; 77(5):773-7. PubMed ID: 9688312
    [Abstract] [Full Text] [Related]

  • 4. Dose response of saccharin in induction of urinary bladder hyperplasias in Fischer 344 rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Nakanishi K, Hagiwara A, Shibata M, Imaida K, Tatematsu M, Ito N.
    J Natl Cancer Inst; 1980 Nov 31; 65(5):1005-10. PubMed ID: 6933236
    [Abstract] [Full Text] [Related]

  • 5. Strain differences in N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis in rats.
    Nakanowatari J, Fukushima S, Imaida K, Ito N, Nagase S.
    Jpn J Cancer Res; 1988 Apr 31; 79(4):453-9. PubMed ID: 3133335
    [Abstract] [Full Text] [Related]

  • 6. Vascular endothelial growth factor mRNA levels as a biomarker for short-term N-butyl-N-(4-hydroxybutyl) nitrosamine-induced rat bladder carcinogenesis bioassay.
    Wakui S, Mutou T, Takahashi H, Ikegami M, Wanibuchi H, Fukushima S.
    J Appl Toxicol; 2015 Feb 31; 35(2):181-90. PubMed ID: 24888239
    [Abstract] [Full Text] [Related]

  • 7. Suppressive effect of 1,4-phenylene diisothiocyanate on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice.
    Sugie S, Vinh PQ, Rahman KM, Ushida J, Kohno H, Suzuki R, Hara A, Quang le B, Tanaka T, Mori H.
    Int J Cancer; 2005 Nov 20; 117(4):524-30. PubMed ID: 15929075
    [Abstract] [Full Text] [Related]

  • 8. Trisodium nitriloacetate monohydrate: promoting effect in urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Hiasa Y, Kitahori Y, Konishi N, Shimoyama T, Miyashiro A.
    J Natl Cancer Inst; 1985 Jan 20; 74(1):235-9. PubMed ID: 3855482
    [Abstract] [Full Text] [Related]

  • 9. Summation effects of uracil and other promoters on epithelial lesion development in the F344 rat urinary bladder initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    de Camargo JL, Shirai T, Kato T, Asamoto M, Fukushima S.
    Jpn J Cancer Res; 1991 Nov 20; 82(11):1220-5. PubMed ID: 1752781
    [Abstract] [Full Text] [Related]

  • 10. Dose response of N-butyl-N-(4-hydroxybutyl)nitrosamine on urinary bladder carcinogenesis in mutant ODS rats lacking L-ascorbic acid synthesizing ability.
    Mori S, Murai T, Takeuchi Y, Toyama M, Makino S, Konishi T, Hayashi Y, Kurata Y, Fukushima S.
    Cancer Lett; 1990 Feb 20; 49(2):139-45. PubMed ID: 2306707
    [Abstract] [Full Text] [Related]

  • 11. Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats.
    Grubbs CJ, Lubet RA, Koki AT, Leahy KM, Masferrer JL, Steele VE, Kelloff GJ, Hill DL, Seibert K.
    Cancer Res; 2000 Oct 15; 60(20):5599-602. PubMed ID: 11059745
    [Abstract] [Full Text] [Related]

  • 12. Inhibitory effects of 1,3-diaminopropane, an ornithine decarboxylase inhibitor, on rat two-stage urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Salim EI, Wanibuchi H, Morimura K, Kim S, Yano Y, Yamamoto S, Fukushima S.
    Carcinogenesis; 2000 Feb 15; 21(2):195-203. PubMed ID: 10657958
    [Abstract] [Full Text] [Related]

  • 13. Loss of heterozygosity in (LewisxF344)F1 rat urinary bladder tumors induced with N-butyl-N-(4-hydroxybutyl)nitrosamine followed by dimethylarsinic acid or sodium L-ascorbate.
    Chen T, Na Y, Wanibuchi H, Yamamoto S, Lee CC, Fukushima S.
    Jpn J Cancer Res; 1999 Aug 15; 90(8):818-23. PubMed ID: 10543252
    [Abstract] [Full Text] [Related]

  • 14. Involvement of toxicity as an early event in urinary bladder carcinogenesis induced by phenethyl isothiocyanate, benzyl isothiocyanate, and analogues in F344 rats.
    Akagi K, Sano M, Ogawa K, Hirose M, Goshima H, Shirai T.
    Toxicol Pathol; 2003 Aug 15; 31(4):388-96. PubMed ID: 12851104
    [Abstract] [Full Text] [Related]

  • 15. Combined effects of L-ascorbic acid, citric acid or their sodium salts on tumor induction by N-butyl-N-(4-hydroxybutyl)nitrosamine or N-ethyl-N-(4-hydroxybutyl)nitrosamine in the rat urinary bladder.
    Inoue T, Imaida K, Suzuki E, Okada M, Fukushima S.
    Cancer Lett; 1988 Jun 30; 40(3):265-73. PubMed ID: 3383181
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Promoting effect of the peroxisome proliferator, clofibrate, but not di(2-ethylhexyl)phthalate, on urinary bladder carcinogenesis in F344 rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Hagiwara A, Tamano S, Ogiso T, Asakawa E, Fukushima S.
    Jpn J Cancer Res; 1990 Dec 30; 81(12):1232-8. PubMed ID: 2125992
    [Abstract] [Full Text] [Related]

  • 18. Inhibitory effect of an aromatic retinoic acid analog on urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Murasaki G, Miyata Y, Babaya K, Arai M, Fukushima S, Ito N.
    Gan; 1980 Jun 30; 71(3):333-40. PubMed ID: 7418979
    [Abstract] [Full Text] [Related]

  • 19. Summation effect of uracil on the two-stage and multistage models of urinary bladder carcinogenesis in F344 rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Masui T, Shirai T, Takahashi S, Mutai M, Fukushima S.
    Carcinogenesis; 1988 Nov 30; 9(11):1981-5. PubMed ID: 3180336
    [Abstract] [Full Text] [Related]

  • 20. Low susceptibility of Long-Evans Cinnamon rats to N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis and inhibitory effect of urinary copper.
    Chone Y, Kinouchi T, Yamada T, Suzuki Y, Kitaura K, Jiao Z, Minami T, Bando Y, Uehara H, Mochizuki M, Ohnishi Y, Izumi K.
    Jpn J Cancer Res; 2000 Jan 30; 91(1):16-24. PubMed ID: 10744040
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.